May 13, 2025:

This month, the Big Ten Cancer Research Consortium highlights Michigan State University as our featured member. Daniel Isaac, DO, MS, serves as the director of clinical research at Michigan State University Division of Hematology/Oncology.

Dr. Isaac joined faculty at Michigan State University in 2019. His research interests are focused on genitourinary malignancies. His current research includes investigations of novel biomarkers in prostate cancer. Dr. Isaac also currently serves on the board of the Michigan Society of Hematology Oncology and has been selected as President-elect.

Dr. Isaac earned a Master of Science in Biomechanics and Mechanical Engineering, as well as a Doctor of Osteopathic Medicine from the Edward Via College of Osteopathic Medicine at Virginia Tech.

Outside of work, Dr. Isaac enjoys his time outdoors, often running and hiking. As a father of three children, his favorite activity is spending time with his family and traveling to new places with them.

About the Big Ten Cancer Research Consortium: The Big Ten Cancer Research Consortium was created in 2013 to transform the conduct of cancer research through collaborative clinical trials and observational studies that seek to improve the lives of cancer patients in the diverse communities we serve by leveraging the scientific and clinical expertise of Big Ten universities. The Big Ten Cancer Research Consortium creates a unique team research culture to drive science rapidly from ideas to treatment and prevention. Within this innovative environment, today’s research leaders collaborate with and mentor the research leaders of tomorrow. Since its founding, the Big Ten CRC has activated nearly 40 clinical trials across a wide range of cancer types, more than 1,000 participants have enrolled in Big Ten CRC studies, and more than 500 researchers have joined Big Ten CRC Clinical Trial Working Groups.

About the Big Ten Conference: The Big Ten Conference is an association of world-class universities whose member institutions share a common mission of research, graduate, professional and undergraduate teaching and public service. Founded in 1896, the Big Ten has sustained a comprehensive set of shared practices and policies that enforce the priority of academics in the lives of students competing in intercollegiate athletics and emphasize the values of integrity, fairness and competitiveness. The broad-based programs of the 18 Big Ten institutions provide direct financial support for more than 11,000 participation opportunities on 350 teams in 42 different sports. The Big Ten sponsors 28 official conference sports, 14 for men and 14 for women. For more information, visit www.bigten.org.